Leaflet VAXZEVRIA suspension for injection
Product code: W67527001 Quantity: 10
Indicated for: COVID-19
Route of administration: injectable
Substance: COVID-19 vaccine (ChAdOx1-S [recombinant]) (vaccine)
ATC: J07BX03 (Antiinfectives for systemic use | Viral vaccines | Other viral vaccines)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
Store in the refrigerator as instructed in the leaflet.
Store protected from light.
The COVID-19 vaccine (ChAdOx1-S [recombinant]) is used to prevent infection with the SARS-CoV-2 virus, responsible for the COVID-19 pandemic. This vaccine uses a non-replicating viral vector based on a genetically modified chimpanzee adenovirus (ChAdOx1) to express the SARS-CoV-2 spike protein.
The vaccine is administered intramuscularly, usually in two doses, 4-12 weeks apart, according to the manufacturer's recommendations. It is intended for adults and adolescents, and its efficacy has been demonstrated in preventing severe forms of COVID-19, hospitalizations, and deaths.
Common side effects include pain at the injection site, fever, fatigue, headache, and muscle aches. In very rare cases, thrombotic events associated with thrombocytopenia have been reported.
The COVID-19 vaccine (ChAdOx1-S [recombinant]) is an essential measure in combating the pandemic, helping to reduce virus transmission and protect public health.
General data about VAXZEVRIA
- Substance: COVID-19 vaccine (ChAdOx1-S [recombinant])
- Date of latest medicines list: 01-05-2021
- Product code: W67527001
- Pharmaceutical form: suspension for injection
- Quantity: 10
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
